Protagonist Therapeutics Statistics
Total Valuation
PTGX has a market cap or net worth of $3.65 billion. The enterprise value is $3.00 billion.
Market Cap | 3.65B |
Enterprise Value | 3.00B |
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PTGX has 62.21 million shares outstanding. The number of shares has increased by 4.64% in one year.
Current Share Class | 62.21M |
Shares Outstanding | 62.21M |
Shares Change (YoY) | +4.64% |
Shares Change (QoQ) | +0.87% |
Owned by Insiders (%) | 1.03% |
Owned by Institutions (%) | 86.25% |
Float | 43.16M |
Valuation Ratios
The trailing PE ratio is 72.74.
PE Ratio | 72.74 |
Forward PE | n/a |
PS Ratio | 17.62 |
Forward PS | 35.68 |
PB Ratio | 5.47 |
P/TBV Ratio | 5.48 |
P/FCF Ratio | 98.69 |
P/OCF Ratio | 92.59 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 120.62, with an EV/FCF ratio of 80.85.
EV / Earnings | 57.64 |
EV / Sales | 14.34 |
EV / EBITDA | 120.62 |
EV / EBIT | 125.10 |
EV / FCF | 80.85 |
Financial Position
The company has a current ratio of 16.97, with a Debt / Equity ratio of 0.02.
Current Ratio | 16.97 |
Quick Ratio | 16.85 |
Debt / Equity | 0.02 |
Debt / EBITDA | 0.41 |
Debt / FCF | 0.30 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.61% and return on invested capital (ROIC) is 2.43%.
Return on Equity (ROE) | 8.61% |
Return on Assets (ROA) | 2.25% |
Return on Invested Capital (ROIC) | 2.43% |
Return on Capital Employed (ROCE) | 3.51% |
Revenue Per Employee | $1.66M |
Profits Per Employee | $413,000 |
Employee Count | 126 |
Asset Turnover | 0.31 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, PTGX has paid $1.74 million in taxes.
Income Tax | 1.74M |
Effective Tax Rate | 3.24% |
Stock Price Statistics
The stock price has increased by +36.68% in the last 52 weeks. The beta is 2.33, so PTGX's price volatility has been higher than the market average.
Beta (5Y) | 2.33 |
52-Week Price Change | +36.68% |
50-Day Moving Average | 54.84 |
200-Day Moving Average | 46.60 |
Relative Strength Index (RSI) | 58.32 |
Average Volume (20 Days) | 674,108 |
Short Selling Information
The latest short interest is 6.31 million, so 10.14% of the outstanding shares have been sold short.
Short Interest | 6.31M |
Short Previous Month | 5.76M |
Short % of Shares Out | 10.14% |
Short % of Float | 14.62% |
Short Ratio (days to cover) | 9.78 |
Income Statement
In the last 12 months, PTGX had revenue of $209.18 million and earned $52.04 million in profits. Earnings per share was $0.80.
Revenue | 209.18M |
Gross Profit | 209.18M |
Operating Income | 23.98M |
Pretax Income | 172.60M |
Net Income | 52.04M |
EBITDA | 24.87M |
EBIT | 23.98M |
Earnings Per Share (EPS) | $0.80 |
Balance Sheet
The company has $570.47 million in cash and $11.28 million in debt, giving a net cash position of $661.68 million or $10.64 per share.
Cash & Cash Equivalents | 570.47M |
Total Debt | 11.28M |
Net Cash | 661.68M |
Net Cash Per Share | $10.64 |
Equity (Book Value) | 668.02M |
Book Value Per Share | 10.76 |
Working Capital | 567.02M |
Cash Flow
In the last 12 months, operating cash flow was $39.54 million and capital expenditures -$2.44 million, giving a free cash flow of $37.10 million.
Operating Cash Flow | 39.54M |
Capital Expenditures | -2.44M |
Free Cash Flow | 37.10M |
FCF Per Share | $0.60 |
Margins
Gross margin is 100.00%, with operating and profit margins of 11.46% and 24.88%.
Gross Margin | 100.00% |
Operating Margin | 11.46% |
Pretax Margin | 25.71% |
Profit Margin | 24.88% |
EBITDA Margin | 11.89% |
EBIT Margin | 11.46% |
FCF Margin | 17.74% |
Dividends & Yields
PTGX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -4.64% |
Shareholder Yield | -4.64% |
Earnings Yield | 1.42% |
FCF Yield | 1.01% |
Analyst Forecast
The average price target for PTGX is $70.13, which is 19.68% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $70.13 |
Price Target Difference | 19.68% |
Analyst Consensus | Strong Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | 1.67% |
EPS Growth Forecast (5Y) | 0.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
PTGX has an Altman Z-Score of 31.97 and a Piotroski F-Score of 4.
Altman Z-Score | 31.97 |
Piotroski F-Score | 4 |